Skip to main content

GOLDMAN SACHS GROUP INC

Position in MYGN — Myriad Genetics Inc

CIK 886982 NEW YORK, NY

Position in MYGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$10,647,414
-$2,638,319 QoQ
Shares Held
2,366,092
+9.5% QoQ
Ownership
2.51%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98% Shared 1% None 1%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $5,828,014,412 across 35 Diagnostics & Research names. MYGN ranks #26 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,647,414 2,366,092
2025-12-31 $13,285,733 2,160,282
2025-09-30 $15,557,360 2,151,779
2025-06-30 $6,815,139 1,283,454
2025-03-31 $6,334,022 714,095
2024-12-31 $10,562,334 770,411
2024-09-30 $25,031,200 913,881
2024-06-30 $21,472,798 877,874
2024-03-31 $19,351,267 907,658
2023-12-31 $20,824,109 1,087,989
2023-09-30 $19,103,976 1,191,021
2023-06-30 $27,226,300 1,174,560
2023-03-31 $32,117,960 1,382,607
2022-12-31 $20,195,249 1,391,816
2022-09-30 $30,953,884 1,622,321
2022-06-30 $23,653,360 1,301,781
2022-03-31 $39,625,513 1,572,441
2021-12-31 $51,039,603 1,849,261
2021-09-30 $68,811,281 2,131,040
2021-06-30 $67,725,219 2,214,690
2021-03-31 $40,697,368 1,336,531
2020-12-31 $29,626,747 1,498,571
2020-09-30 $12,755,075 978,150
2020-06-30 $12,951,991 1,142,151
2020-03-31 $8,017,205 560,252